MedTrace Logo

RCT of CBT Combined With D-Cycloserine for Treating PTSD

NCT00452231 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-03-27

No results posted yet for this study

Summary

The purpose of this study is to investigate if the effectiveness of cognitive-behavioral therapy for post-traumatic stress disorder can be increased by combining it with D-cycloserine (TCC/D-cycloserine) by comparing with a placebo (TCC/placebo).

Conditions

  • Post-Traumatic Stress Disorder

Interventions

DRUG

D-cycloserine

BEHAVIORAL

Cognitive-Behavioral Therapy

Sponsors & Collaborators

  • Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal

    collaborator OTHER

  • Université de Montréal

    lead OTHER

Principal Investigators

  • Stéphane Guay · Université de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2008-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00452231 on ClinicalTrials.gov